Announced Mon, 3 Nov · 17:53 IST

Emcure Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Emcure Pharmaceuticals has scheduled an earnings call for investors and analysts on Tuesday, November 11, 2025, at 3:00 p.m. IST. The call will cover the company's unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. International dial-in numbers have been provided for participants from Hong Kong, Singapore, the UK, and the USA, along with Indian access numbers. The transcript and audio recording will be uploaded to the company's website after the call.

Likely market impact

This is a routine procedural announcement and not a material event on its own. Investors should watch the call for management commentary on Q2 FY26 revenue, margins, and growth outlook, which could influence near-term sentiment in the stock.